August 18, 2022— A pair of recent studies add to the growing body of research concluding that hospitals participating in the 340B drug pricing program are providing the lion’s share of care for patients who are most in need. These include people who cannot afford the services they need and people who historically have been underserved by the broader health care system. The … [Read more...]
New Law Protects 340B Hospitals from Eligibility Loss During COVID-19
March 31, 2022– Safety-net hospitals have been on the front lines of our national response to the COVID-19 public health emergency since it started in 2020. They have had to absorb massive changes in their day-to-day operations to serve waves of COVID patients. They scrambled to increase hospital bed and intensive care unit capacity, cared for COVID patients while taking … [Read more...]
340B Hospitals Continue to Answer the Call to COVID Service
Nov. 12, 2021– In January 2021, St. Luke’s Health System Senior Director of Pharmacy Scott Milner was the featured guest on 340B Health’s podcast, 340B Insight, to discuss the initial rollout of COVID-19 vaccines throughout the U.S. “For me, the vaccine's greatest side effect is hope,” Scott said at the time. Fast forward 10 months, and much has happened in the national … [Read more...]
Hope and Vigilance in the 340B Community
By Maureen Testoni August 9, 2021– From my perspective, last month’s 340B Coalition Summer Conference was notable for several reasons. The first was that it marked the 25th year of hosting the conference, reflecting on a quarter-century of work to ensure the 340B drug pricing program delivers on its benefits for safety-net hospitals, health centers, and clinics with a … [Read more...]
Bipartisan Congressional Calls to Protect 340B Intensify
Aug. 4, 2021– A pair of lawmakers is working to advance the latest example of bipartisan, pro-340B legislation in Congress. Reps. Abigail Spanberger (D-Va.) and David McKinley (R-W.V.) recently introduced the Preserving Rules Ordered for The Entities Covered Through 340B Act, also known as the PROTECT 340B Act, and are gathering cosponsors from both sides of the political … [Read more...]
340B Providers Contemplate the Challenges Met and Prepare for the Ones Ahead
By Maureen Testoni March 11, 2021– In this pandemic-focused world we all find ourselves in, it seems only fitting that one of my highlights of this past month was getting the chance to meet Fauci. No, I’m not talking about the esteemed Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who has become a household name over the past … [Read more...]
Drug Giant’s Revenues Soar While 340B Cuts Sting
February 10, 2021– While hospitals across the country have been struggling to stay afloat and serve the health needs of a nation during a historic pandemic, one of the largest drug companies in the U.S. has been boosting its already huge profits by denying safety-net providers the drug discounts that the 340B drug pricing program requires. Two new reports show that as drug … [Read more...]